Trial site
Nanyang First People's Hospital
- 12running trials
- 8closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Psoriasis4 trials
- Heart failure3 trials
- Vitiligo3 trials
- Type 2 diabetes2 trials
- COPD1 trial
- Coronary artery disease1 trial
- Crohn's disease1 trial
- Hepatitis B1 trial
- Idiopathic pulmonary fibrosis1 trial
- Liver and biliary tract cancer1 trial
- Lupus (SLE)1 trial
- Myasthenia gravis1 trial
- and 1 more
- Phase
- Phase 314 trials
- Phase 22 trials
- Phase 2/32 trials
- Phase 41 trial
- Status
- Completed8 trials
- Recruiting7 trials
- Active, not recruiting3 trials
- Not yet recruiting2 trials
- Lead sponsor
- Boehringer Ingelheim2 trials
- Eli Lilly and Company2 trials
- Beijing InnoCare Pharma Tech Co., Ltd.1 trial
- Biogen1 trial
- Capital Medical University1 trial
- and 13 more
Running trials
Not yet recruiting
A Phase 3 Study of Povorcitinib Phosphate in Chinese Adults With Nonsegmental Vitiligo
Recruiting
Recruiting
Recruiting
Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure2 recruiting
- Vitiligo2 recruiting
- COPD1 recruiting
- Crohn's disease1 recruiting
- Hepatitis B1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Liver and biliary tract cancer1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Completed
Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis
Completed
Completed
Completed
HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.
Completed
Completed
Completed
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)
Site data: ClinicalTrials.govUpdated 17 Nov 2026